Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 10 of the 11 references it cites were found in a registry or an index.

Machine learning in medicine: Addressing ethical challenges

Open access

Abstract

A recent United Kingdom survey reports that 63% of the adult population is uncomfortable with allowing personal data to be used to improve healthcare and is unfavorable to artificial intelligence (AI) systems replacing doctors and nurses in tasks they usually perform [1].Another study, conducted in Germany, found that medical students-the doctors of tomorrow-overwhelmingly buy into the promise of AI to improve medicine (83%) but are more skeptical that it will establish conclusive diagnoses in, for instance, imaging exams (56% disagree) [2].When asked about the prospects of AI, United States decision-makers at healthcare organizations are confident that it will improve medicine, but roughly half of them think it will produce fatal errors, will not work properly, and will not meet currently hyped expectations [3].These survey data resonate to the ethical and regulatory challenges that surround AI in healthcare, particularly privacy, data fairness, accountability, transparency, and liability.Successfully addressing these will foster the future of machine learning in medicine (MLm) and its positive impact on healthcare.Ethical and regulatory concerns about MLm can be grouped into three broad categories according to how and where they emerge, namely, around the sources of data needed for MLm and the approaches used in the development and deployment of MLm in clinical practice (for a hypothetical case study, see Fig 1). Data sourcing for MLm must adhere to data protection and privacy requirementsMLm algorithms use data that are subject to privacy protections, requiring that developers pay close attention to ethical and regulatory restrictions at each stage of data processing.Data provenance and consent for use and reuse are of particular importance [4,5], especially for MLm that requires considerable amounts and large varieties of data.It is very likely that such disparate data will have different conditions of use and/or be bound by different legal protections.A prominent example is the newly enacted European General Data Protection Regulation (GDPR), which sets out specific informed consent requirements for data uses and grants data subjects several rights that must be respected by those processing their data [6].Moreover, this law applies to data from residents of the European Union (EU) irrespective of where the data are processed.Data that are used to train algorithms must have the necessary use authorizations, but determining which data uses are permitted for a given purpose is not an easy feat.This will also depend on data type, jurisdiction, purpose of use, and oversight models.Ethical and regulatory concerns around health data have been debated for some time, and regulation such as GDPR is emblematic of legislative motivation to address novel digital challenges.However, different jurisdictions have reached and can be expected to reach different conclusions.Compare, for example, the GDPR with the Health Insurance Portability and

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pmed.1002689

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Imagine a medical software company developing a machine learning–based device. The device performs fully automated analysis of histopathology slides from cancer patients and predicts genetic mutations in tumors solely based on these images. This inferred genetic information can be used either for prognostic purposes or to detect an indication for a targeted therapy. Users will not know which features of the images the algorithm associates with mutated genes or the biological explanation for these associations. The selling propositions of the device are that it can infer valuable genetic information early in the diagnostic process and be used in contexts in which genetic testing is not available by analyzing images shared by pathologists on a cloud-based platform. MLm, machine learning in medicine.
Fig 1 Imagine a medical software company developing a machine learning–based device. The device performs fully automated analysis of histopathology slides from cancer patients and predicts genetic mutations in tumors solely based on these images. This inferred genetic information can be used either for prognostic purposes or to detect an indication for a targeted therapy. Users will not know which features of the images the algorithm associates with mutated genes or the biological explanation for these associations. The selling propositions of the device are that it can infer valuable genetic information early in the diagnostic process and be used in contexts in which genetic testing is not available by analyzing images shared by pathologists on a cloud-based platform. MLm, machine learning in medicine.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

8 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 1

  1. The American Medical Association. AMA passes first policy recommendations on augmented intelligence. 2018 Jun 14 [Cited 19 Sept 2018]. https://www.ama-assn.org/ama-passes-first-policy-recommendations-augmented-intelligence.

Cited by

See all 970

Metadata

Authors
Vayena, E., Blasimme, A., & Cohen, I. G.
Affiliations
  • ETH Zurich (CH)
  • Harvard University (US)
Corresponding author
Vayena, Effy
Venue
PLOS Medicine
Published
2018-11-06
Volume
15
Issue
11
Pages
e1002689
ISSN
  • 1549-1277 (ISSN-L)
  • 1549-1676
OpenAlex
W2899768131
Cited by
912
References
11
Citations by year
2026: 228 · 2025: 165 · 2024: 126 · 2023: 104 · 2022: 81 · 2021: 103 · 2020: 61 · 2019: 42 · 2018: 2
FWCI
14.10
Type
journal article
Language
en
Open access
Locations
  • PLoS Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Repository for Publications and Research Data (ETH Zurich) (submittedVersion, cc-by)
  • ETH Zürich Research Collection (cc-by)
Funders
  • Celgene
  • Novo Nordisk
  • Novo Nordisk Fonden (NNF17SA0027784)
Topics
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
  • Physical Sciences › Computer Science › Artificial Intelligence › Ethics and Social Impacts of AI
  • Physical Sciences › Computer Science › Artificial Intelligence › Explainable Artificial Intelligence (XAI)
Keywords
machine learning in medicine, artificial intelligence in healthcare, AI ethics, regulatory challenges, health data privacy, data protection, General Data Protection Regulation, informed consent, data provenance, data fairness, algorithmic accountability, transparency, liability, data sourcing, medical students' attitudes, public trust in AI
MeSH terms
Machine Learning, Attitude of Health Personnel, Attitude to Computers, Confidentiality, Delivery of Health Care, Humans, Medical Records, Public Opinion, Self Care, Computer Security, Trust, Data Mining

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Machine learning in medicine: Addressing ethical challenges. https://app.cochat.ai/papers/10.1371/journal.pmed.1002689
The paper
Vayena, E., Blasimme, A., & Cohen, I. G. (2018). Machine learning in medicine: Addressing ethical challenges. PLOS Medicine. https://doi.org/10.1371/journal.pmed.1002689

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.